Skip to content

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
6.2×-1.0×
Gilead Sciences logo
Gilead SciencesGILD
7.4×+0.1×
Immunome logo
ImmunomeIMNM
4.2×+2.3×
Nuvation Bio logo
Nuvation BioNUVB
4.7×+3.2×
Immunovant, Inc. logo
Immunovant, Inc.IMVT
5.9×+1.8×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.1×+1.3×

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.98B+32.4%
Enterprise value$1.83B+33.2%
P/S6.9×-0.1×

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s price / book?
Iovance Biotherapeutics, Inc. (IOVA) reported price / book of 2× in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s price / book changed year-over-year?
Iovance Biotherapeutics, Inc.'s price / book increased by 40.9% year-over-year, from 1.4× to 2×.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s price / book?
Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s price / book has grown at a -31.7% compound annual growth rate (CAGR), from 10.4× to 1.6×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.